BioSpace News Archive

Arcadia Biosciences, Inc. announced the U.S. Patent and Trademark Office has awarded the company a patent for reduced gluten grains.

Clovis Oncology, Inc. has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need.

Baylis Medical announced the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution.

Insulet Corporation announced it has received clearance from the U.S. Food and Drug Administration for an Alternate Controller Enabled Infusion Pump.

The Canadian Mental Health Association kicks off its fourth annual three-day Mental Health for All Conference.

GenScript®, the world’s leading gene synthesis provider, today announced that it will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project, the first grand scale community-wide initiative being undertaken by Genome Project-write and The Center for Excellence in Engineering Biology

To the benefit of millions of people living with uncontrolled psoriasis worldwide, a global consortium of more than 100 physician leaders in dermatology led by the International Psoriasis Council (IPC) has developed a simplified method used to classify psoriasis severity and determine the appropriate course of treatment.

Cardax, Inc. (OTCQB: CDXI) today announced results from the pre-specified interim review of its ongoing CHASE (Cardiovascular Health Astaxanthin Supplement Evaluation) clinical trial.

FogPharma today announced the appointment of Fang Wang, Ph.D., as Vice President of Biology and Nancy Wilker, Ph.D., J.D., as Vice President and Lead IP Counsel.

Promising results from the preclinical study conducted by Menarini Ricerche on MEN1611, a potent and selective orally available phosphatidylinositol 3-kinase (PI3K) inhibitor currently in development for the treatment of breast cancer.